• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients.

作者信息

Favalli Ennio Giulio, De Lucia Orazio, Biggioggero Martina, Del Papa Nicoletta, Caporali Roberto

机构信息

Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Italy

Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Italy.

出版信息

Ann Rheum Dis. 2021 May;80(5):e75. doi: 10.1136/annrheumdis-2020-218068. Epub 2020 Jun 19.

DOI:10.1136/annrheumdis-2020-218068
PMID:32561608
Abstract
摘要

相似文献

1
Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients.抗疟药在新冠病毒疾病中的作用：来自一组风湿性疾病患者的观察数据。
Ann Rheum Dis. 2021 May;80(5):e75. doi: 10.1136/annrheumdis-2020-218068. Epub 2020 Jun 19.
2
Response to: 'The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients' by Favalli .对法瓦利的《抗疟药在COVID-19中的作用：一组风湿性疾病患者的观察数据》的回应
Ann Rheum Dis. 2021 May;80(5):e76. doi: 10.1136/annrheumdis-2020-218175. Epub 2020 Jun 19.
3
Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie .对于抗疟药物在风湿性疾病患者的新型冠状病毒肺炎治疗中明确作用的界定仍为时过早。回应：谢的“羟氯喹降低风湿性疾病患者感染新型冠状病毒肺炎的风险：神话还是现实？”
Ann Rheum Dis. 2021 Jan;80(1):e7. doi: 10.1136/annrheumdis-2020-217633. Epub 2020 Jun 22.
4
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.风湿性疾病患者因 COVID-19 住院的相关特征：来自 COVID-19 全球风湿病联盟医生报告登记处的数据。
Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29.
5
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.在2019冠状病毒病（COVID-19）大流行中，是否将抗疟药作为一种预防性干预措施加以考虑。
Ann Rheum Dis. 2021 Jan;80(1):e8. doi: 10.1136/annrheumdis-2020-217557. Epub 2020 Apr 22.
6
Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.对帕尔佩里斯所著《在严重急性呼吸综合征冠状病毒2（新冠病毒病）大流行中是否将抗疟药用作预防性干预措施》的回应
Ann Rheum Dis. 2021 Jan;80(1):e9. doi: 10.1136/annrheumdis-2020-217634. Epub 2020 May 4.
7
Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.羟氯喹能保护风湿病患者免受新型冠状病毒肺炎（COVID-19）感染吗？对Heldwein和Calado所著的《羟氯喹能预防新型冠状病毒肺炎（COVID-19）传播吗？》以及Joob和Wiwanitkit所著的《系统性红斑狼疮、羟氯喹与非系统性红斑狼疮的新型冠状病毒肺炎（COVID-19）患者：一则评论》的回应
Ann Rheum Dis. 2020 Jun;79(6):e62. doi: 10.1136/annrheumdis-2020-217524. Epub 2020 Apr 23.
8
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy.抗疟药物治疗患者对 COVID-19 的易感性：意大利北部艾米利亚-罗马涅地区的一项基于人群的研究。
Arthritis Rheumatol. 2021 Jan;73(1):48-52. doi: 10.1002/art.41475. Epub 2020 Nov 27.
9
Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.慢性使用羟氯喹并未在巴西的一大群风湿疾病患者中预防 COVID-19。
Adv Rheumatol. 2021 Oct 7;61(1):60. doi: 10.1186/s42358-021-00217-0.
10
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.羟氯喹暴露前预防对风湿性疾病患者感染 SARS-CoV-2 的影响：一项基于人群的队列研究。
Clin Microbiol Infect. 2021 Apr;27(4):611-617. doi: 10.1016/j.cmi.2020.12.003. Epub 2020 Dec 11.

引用本文的文献

1
The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches.2019冠状病毒病与类风湿性关节炎的交叉点：共同机制、治疗挑战及潜在治疗方法
Aging Dis. 2023 Aug 1;14(4):1196-1213. doi: 10.14336/AD.2023.0406.
2
Systemic Lupus Erythematosus and Coronavirus Disease 2019.系统性红斑狼疮与2019冠状病毒病
Rheumatol Immunol Res. 2021 Apr 13;2(1):15-18. doi: 10.2478/rir-2021-0004. eCollection 2021 Mar.
3
Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series.
类风湿关节炎患者接种灭活 SARS-CoV-2 疫苗的免疫原性：病例系列研究。
Front Public Health. 2022 Apr 25;10:875558. doi: 10.3389/fpubh.2022.875558. eCollection 2022.
4
COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges.COVID-19 与类风湿关节炎的相互作用：新兴关联、治疗选择与挑战。
Cells. 2021 Nov 24;10(12):3291. doi: 10.3390/cells10123291.
5
Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review.羟氯喹作为COVID-19的化学预防剂：临床药理学综述
Front Pharmacol. 2020 Dec 17;11:593099. doi: 10.3389/fphar.2020.593099. eCollection 2020.
6
Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic.风湿性肌肉骨骼疾病与2019冠状病毒病：大流行前6个月综述
Front Med (Lausanne). 2020 Oct 9;7:562142. doi: 10.3389/fmed.2020.562142. eCollection 2020.